…suggests psilocybin for terminally ill patients has financial interest…
As part of their efforts to better understand DEA’s administrative process, Aggarwal [Washington State, Seattle] and his counsel have submitted several Freedom of Information Act (FOIA) requests for relevant documents. DEA’s FOIA policy states that it will consider waiving or reducing fees if the requester is shows that the information is “in the public interest because it is likely to contribute significantly to public understanding of the operations or activities of the government and is not primarily in the commercial interest of the requester.”
“If I was somehow attempting to monopolize this, then I can understand a concern over commercial interest,” he said. “But since the outcome of our rescheduling petition and other matters we have before the DEA would impact wider public policy and federal agency practice, the whole country could stand to benefit from the information requested in the FOIA filings and in the overall outcome of our case. Other private commercial interests are being served with the DEA refusing to share this information and grant our petitions and waivers, since this is continuing to restrict the number of entities that have ability to work with psilocybin legally,” he added.
Original Article (Marijuana Moment):
DEA suggests doctor seeking psilocybin for terminally ill patients has financial interest, so it won’t waive records fee
Artwork Fair Use: Fahrradtechnik
